LBA21InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial. (23rd October 2018)

• Record Type: Journal Article
• Authors: Rao, S; Sclafani, F; Eng, C; Grønlie Guren, M; Adams, R A; Benson, A; Sebag-Montefiore, D; Segelov, E; Bryant, A; Peckitt, C; Roy, A; Seymour, M T; Welch, J; Saunders, M P; Muirhead, R; Bridgewater, J; Falk, S; Glynne-Jones, R; Arnold, D; Cunningham, D
• Is Part Of: Annals of oncology. Volume 29(2018)Supplement 8
• Publication Date: 2018-10-23
• Subjects: Oncology -- Periodicals; 616.992
• DOI: 10.1093/annonc/mdy424.022
• Languages: English
• ISSNs: 0923-7534